We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
RNLX

Price
0.14
Stock movement up
+0.00 (0.92%)
Company name
Renalytix AI
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Health Information Services
Market cap
11.78M
Ent value
22.93M
Price/Sales
5.15
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
0.76%
1 year return
-66.27%
3 year return
-78.84%
5 year return
-
10 year return
-
Last updated: 2025-04-12

DIVIDENDS

RNLX does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales5.15
Price to Book-
EV to Sales10.02

FINANCIALS

Per share

Per share data
Current share count82.96M
EPS (TTM)-0.24
FCF per share (TTM)-0.22

Income statement

Income statement data
Revenue (TTM)2.29M
Gross profit (TTM)156.00K
Operating income (TTM)-28.89M
Net income (TTM)-33.46M
EPS (TTM)-0.24
EPS (1y forward)-0.19

Margins

Margins data
Gross margin (TTM)6.82%
Operating margin (TTM)-1261.90%
Profit margin (TTM)-1461.60%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash4.68M
Net receivables722.00K
Total current assets6.12M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment515.00K
Total assets7.97M
Accounts payable2.61M
Short/Current long term debt8.54M
Total current liabilities11.49M
Total liabilities15.83M
Shareholder's equity-7.85M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-30.11M
Capital expenditures (TTM)4.00K
Free cash flow (TTM)-30.11M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-419.67%
Return on Invested Capital-4912.78%
Cash Return on Invested Capital-4422.17%

STOCK INFORMATION

Stock chart

Stock price data
Open0.15
Daily high0.16
Daily low0.14
Daily Volume71K
All-time high34.78
1y analyst estimate2.50
Beta2.10
EPS (TTM)-0.24
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Downside potential data
RNLXS&P500
Current price drop from All-time high-99.59%-0.52%
Highest price drop-99.62%-56.47%
Date of highest drop2 Dec 20249 Mar 2009
Avg drop from high-69.10%-11.07%
Avg time to new high41 days12 days
Max time to new high848 days1805 days
COMPANY DETAILS
RNLX (Renalytix AI) company logo
Marketcap
11.78M
Marketcap category
Small-cap
Description
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix Plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; and Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is based in New York, New York.
Employees
0
Website
https://renalytix.com
Investor relations
-
SEC filings
RNLX SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved